Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rehab pathway aims to get back-pain patients back to work sooner

NCT ID NCT07313566

Disease control Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This trial tests a structured rehabilitation pathway for people having lumbar surgery for radicular pain (nerve-related back and leg pain). The pathway includes pre-surgery exercise, early movement after surgery, and active guidance to return to work. 480 participants across multiple hospitals will be randomly assigned to either this new rehab plan or usual care. The main goal is to see if the pathway reduces the time it takes to return to work.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured rehabilitation pathway (prehabilitation, perioperative and postoperative rehab, case management, early return-to-work guidance)
What this could lead to
If successful, this could provide a proven rehab plan that helps people get back to work sooner after back surgery.
What could go wrong
This is a relatively early-stage trial (cluster randomized) and the effect may vary across hospitals. The intervention is complex and may be hard to implement consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 480 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Radicular pain (for ≥ 6 weeks prior to screening), with a clear indication for lumbar spinal surgery ((micro)discectomy, decompression and/or fusion), in accordance with the KCE guidelines (when evidence-based multimodal management has not improved pain or function and radiological findings are consistent with clinical symptoms) * Employed (working or on sick leave for less than 1 year due to spinal pathology) * Age 18 - 65 years * Surgery is scheduled within a timeframe of five days to 2 months after the decision for surgery (4 months for fusion) * For lumbar fusion surgery, the fusion should be restricted to one or two levels * Able to provide written informed consent, implying that the participant is both physically and cognitively capable of understanding the study information and signing the consent form independently. Exclusion Criteria: Patients are not eligible for the trial in case of any of the following criteria: * Lumbar surgery performed for malignant disease, spinal fracture, infectious spinal disease * Insufficient knowledge of Dutch or French language to receive education in the recruiting center and to complete the questionnaires (consistent with the language spoken in the recruiting centre) * Immediate surgery via emergency admission that precludes prehabilitation * Revision fusion surgery * Non-residency in Belgium

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lumbar radiculopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

radiculopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lumbar radiculopathy Radicular low back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Delta Roeselare

    NOT_YET_RECRUITING

    Roeselare, Belgium

  • AZ Groeninge Kortrijk

    NOT_YET_RECRUITING

    Kortrijk, Belgium

  • AZ Herentals

    NOT_YET_RECRUITING

    Herentals, Belgium

  • AZ Sint Jan Brugge

    RECRUITING

    Bruges, Belgium

  • AZ Sint Maarten Mechelen

    NOT_YET_RECRUITING

    Mechelen, Belgium

  • CSPO

    NOT_YET_RECRUITING

    Ottignies, Belgium

  • Centre Hospitalier de Wallonie Picarde

    NOT_YET_RECRUITING

    Tournai, Belgium

  • Grand Hôpital de Charleroi

    NOT_YET_RECRUITING

    Charleroi, Belgium

  • Heilig Hart Lier

    RECRUITING

    Lier, Belgium

  • Jan Yperman ziekenhuis

    NOT_YET_RECRUITING

    Ieper, Belgium

  • Jessa Ziekenhuis

    NOT_YET_RECRUITING

    Hasselt, Belgium

  • UZ Brussel

    NOT_YET_RECRUITING

    Brussels, Belgium

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • ZAS

    NOT_YET_RECRUITING

    Antwerp, Belgium

  • ZOL Genk

    RECRUITING

    Genk, Belgium

  • Ziekenhuis Geel

    NOT_YET_RECRUITING

    Geel, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.